Lamivudine is safe and effective in fulminant hepatitis B [1]

Journal of Hepatology

Volumn 30, Issue 3, 1999, Pages 551-

  Santantonio, T ^a   Mazzola, M ^a   Pastore, G ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LAMIVUDINE;

ADULT; CASE REPORT; CHRONIC DISEASE; DRUG EFFICACY; DRUG SAFETY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LETTER; MALE; PRIORITY JOURNAL;

EID: 0032911361     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80119-6     Document Type: Letter

References (3)

1. C-L Lai C-K Ching AK-M Tung E Li J Young A Hill Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: a placebo-controlled trial Hepatology 25 1997 241 244
2. MM Bartholomew RW Jansen LJ Jeffers KR Reddy LC Johnson H Bunsendahl Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation Lancet 349 1997 20 22
3. S Zeuzem RA de Man P Honkoop WK Roth SW Schalm JM Schmidt Dynamics of hepatitis B virus infection in vivo J Hepatol 27 1997 431 436